Maze Therapeutics Insider Trades
NASDAQ: MAZEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 60 · $11.45M
- Shares bought / sold
- 0 / 422.96K
- Net activity
- Net selling $11.5 million
Maze Therapeutics insider activity
Over the last 12 months, Maze Therapeutics insiders reported 82 transactions on SEC Form 4: 0 open-market purchases and 60 sales. Insiders bought $0 and sold $11.5 million worth of stock, for net insider selling of $11.5 million. The largest seller was Coloma Jason V, with $6.2 million in reported sales.
The most recent filing shows Coloma Jason V (Chief Executive Officer) selling 2,593 shares at $27.02 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put MAZE's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
MAZE insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 16,141 | $434.74K | Form 4 |
| Oct 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Option exercise | 16,141 | $168.19K | Form 4 |
| Oct 1, 2026 | Coloma Jason VChief Executive Officer | Sale | 31,908 | $862.19K | Form 4 |
| Oct 1, 2026 | Coloma Jason VChief Executive Officer | Sale | 2,593 | $70.07K | Form 4 |
| Sep 29, 2026 | Dandekar AtulCSBO | Sale | 7,500 | $202.92K | Form 4 |
| Sep 29, 2026 | Dandekar AtulCSBO | Option exercise | 7,500 | $78.15K | Form 4 |
| Sep 4, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 9,705 | $254.50K | Form 4 |
| Sep 3, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 59 | $1.52K | Form 4 |
| Sep 3, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 5,130 | $133.45K | Form 4 |
| Sep 3, 2026 | Coloma Jason VChief Executive Officer | Sale | 129 | $3.32K | Form 4 |
| Sep 3, 2026 | Coloma Jason VChief Executive Officer | Sale | 11,282 | $293.48K | Form 4 |
| Sep 3, 2026 | Dandekar AtulCSBO | Sale | 36 | $929.16 | Form 4 |
| Sep 3, 2026 | Dandekar AtulCSBO | Sale | 3,207 | $83.42K | Form 4 |
| Sep 3, 2026 | Courtney PhillipsGC and Corp. Secretary | Sale | 22 | $567.16 | Form 4 |
| Sep 3, 2026 | Courtney PhillipsGC and Corp. Secretary | Sale | 1,990 | $51.77K | Form 4 |
| Sep 2, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 625 | $16.95K | Form 4 |
| Sep 2, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 4,481 | $118.19K | Form 4 |
| Sep 2, 2026 | Coloma Jason VChief Executive Officer | Sale | 1,375 | $37.29K | Form 4 |
| Sep 2, 2026 | Coloma Jason VChief Executive Officer | Sale | 9,852 | $259.86K | Form 4 |
| Sep 2, 2026 | Dandekar AtulCSBO | Sale | 391 | $10.60K | Form 4 |
| Sep 2, 2026 | Dandekar AtulCSBO | Sale | 2,800 | $73.85K | Form 4 |
| Sep 2, 2026 | Courtney PhillipsGC and Corp. Secretary | Sale | 243 | $6.59K | Form 4 |
| Sep 2, 2026 | Courtney PhillipsGC and Corp. Secretary | Sale | 1,738 | $45.84K | Form 4 |
| Sep 1, 2026 | Coloma Jason VChief Executive Officer | Option exercise | 50,000 | — | Form 4 |
| Sep 1, 2026 | Coloma Jason VChief Executive Officer | Sale | 31,908 | $838.78K | Form 4 |
| Sep 1, 2026 | Coloma Jason VChief Executive Officer | Sale | 2,593 | $68.21K | Form 4 |
| Sep 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Option exercise | 20,000 | — | Form 4 |
| Sep 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 16,141 | $425.51K | Form 4 |
| Sep 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Option exercise | 16,141 | $168.19K | Form 4 |
| Sep 1, 2026 | Courtney PhillipsGC and Corp. Secretary | Option exercise | 11,000 | — | Form 4 |
| Sep 1, 2026 | Dandekar AtulCSBO | Option exercise | 12,500 | — | Form 4 |
| Aug 28, 2026 | Dandekar AtulCSBO | Sale | 7,500 | $206.82K | Form 4 |
| Aug 28, 2026 | Dandekar AtulCSBO | Option exercise | 7,500 | $78.15K | Form 4 |
| Aug 13, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 16,142 | $445.62K | Form 4 |
| Aug 13, 2026 | Bernstein HaroldPresident, R&D & CMO | Option exercise | 16,142 | $168.20K | Form 4 |
| Aug 3, 2026 | Coloma Jason VChief Executive Officer | Sale | 1,604 | $43.44K | Form 4 |
| Aug 3, 2026 | Coloma Jason VChief Executive Officer | Sale | 30,304 | $809.54K | Form 4 |
| Aug 3, 2026 | Coloma Jason VChief Executive Officer | Sale | 154 | $4.17K | Form 4 |
| Aug 3, 2026 | Coloma Jason VChief Executive Officer | Sale | 2,439 | $65.16K | Form 4 |
| Jul 29, 2026 | Dandekar AtulCSBO | Sale | 400 | $11.16K | Form 4 |
| Jul 29, 2026 | Dandekar AtulCSBO | Sale | 7,100 | $193.88K | Form 4 |
| Jul 29, 2026 | Dandekar AtulCSBO | Option exercise | 7,500 | $78.15K | Form 4 |
| Jul 1, 2026 | Coloma Jason VChief Executive Officer | Sale | 1,597 | $48.61K | Form 4 |
| Jul 1, 2026 | Coloma Jason VChief Executive Officer | Sale | 30,311 | $907.92K | Form 4 |
| Jul 1, 2026 | Coloma Jason VChief Executive Officer | Sale | 2,593 | $77.73K | Form 4 |
| Jul 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 1,200 | $36.40K | Form 4 |
| Jul 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 13,409 | $400.46K | Form 4 |
| Jul 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Option exercise | 14,609 | $152.23K | Form 4 |
| Jun 29, 2026 | Dandekar AtulCSBO | Sale | 7,500 | $210.15K | Form 4 |
| Jun 29, 2026 | Dandekar AtulCSBO | Option exercise | 7,500 | $78.15K | Form 4 |
| Jun 23, 2026 | Coloma Jason VChief Executive Officer | Sale | 23,865 | $621.67K | Form 4 |
| Jun 22, 2026 | Coloma Jason VChief Executive Officer | Sale | 2,040 | $53.04K | Form 4 |
| Jun 22, 2026 | Coloma Jason VChief Executive Officer | Sale | 1,953 | $50.78K | Form 4 |
| Jun 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 1,600 | $42.17K | Form 4 |
| Jun 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 13,253 | $338.94K | Form 4 |
| Jun 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Option exercise | 14,853 | $154.77K | Form 4 |
| Jun 1, 2026 | Coloma Jason VChief Executive Officer | Sale | 553 | $14.51K | Form 4 |
| Jun 1, 2026 | Coloma Jason VChief Executive Officer | Sale | 6,090 | $159.54K | Form 4 |
| May 29, 2026 | Dandekar AtulCSBO | Sale | 7,500 | $197.55K | Form 4 |
| May 29, 2026 | Dandekar AtulCSBO | Option exercise | 7,500 | $78.15K | Form 4 |
| May 26, 2026 | Coloma Jason VChief Executive Officer | Sale | 25,582 | $665.52K | Form 4 |
| May 22, 2026 | Coloma Jason VChief Executive Officer | Sale | 2,478 | $64.43K | Form 4 |
| May 22, 2026 | Coloma Jason VChief Executive Officer | Sale | 4,504 | $117.10K | Form 4 |
| May 15, 2026 | Coloma Jason VChief Executive Officer | Sale | 116 | $3.02K | Form 4 |
| May 15, 2026 | Coloma Jason VChief Executive Officer | Sale | 1,822 | $47.37K | Form 4 |
| May 14, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 15,000 | $393.35K | Form 4 |
| May 14, 2026 | Bernstein HaroldPresident, R&D & CMO | Option exercise | 15,000 | $156.30K | Form 4 |
| May 4, 2026 | HOMCY CHARLES JDirector | Gift | 7,422 | — | Form 4 |
| May 4, 2026 | Dandekar AtulCSBO | Option exercise | 5,985 | $62.36K | Form 4 |
| May 4, 2026 | Dandekar AtulCSBO | Option exercise | 8,320 | $86.69K | Form 4 |
| Apr 29, 2026 | Dandekar AtulCSBO | Sale | 7,500 | $190.30K | Form 4 |
| Apr 29, 2026 | Dandekar AtulCSBO | Option exercise | 7,500 | $78.15K | Form 4 |
| Apr 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 300 | $9.32K | Form 4 |
| Apr 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 3,348 | $100.64K | Form 4 |
| Apr 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Sale | 11,352 | $331.95K | Form 4 |
| Apr 1, 2026 | Bernstein HaroldPresident, R&D & CMO | Option exercise | 15,000 | $156.30K | Form 4 |
| Apr 1, 2026 | Bachrodt AmySVP, Finance | Sale | 300 | $9.10K | Form 4 |
| Apr 1, 2026 | Bachrodt AmySVP, Finance | Sale | 2,200 | $64.51K | Form 4 |
| Apr 1, 2026 | Bachrodt AmySVP, Finance | Option exercise | 2,500 | $26.05K | Form 4 |
| Mar 30, 2026 | Dandekar AtulCSBO | Sale | 790 | $23.71K | Form 4 |
| Mar 30, 2026 | Dandekar AtulCSBO | Sale | 6,710 | $196.31K | Form 4 |
| Mar 30, 2026 | Dandekar AtulCSBO | Option exercise | 7,500 | $78.15K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4